16-84480545-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020947.4(MEAK7):c.1241C>T(p.Pro414Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000201 in 1,611,568 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 3 hom. )
Consequence
MEAK7
NM_020947.4 missense
NM_020947.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 1.74
Genes affected
MEAK7 (HGNC:29325): (MTOR associated protein, eak-7 homolog) Involved in several processes, including TOR signaling; positive regulation of protein localization to lysosome; and response to insulin. Located in cytosol; lysosomal membrane; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00550133).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEAK7 | NM_020947.4 | c.1241C>T | p.Pro414Leu | missense_variant | 7/8 | ENST00000343629.11 | NP_065998.3 | |
MEAK7 | XM_005256075.3 | c.1241C>T | p.Pro414Leu | missense_variant | 8/9 | XP_005256132.1 | ||
MEAK7 | XM_017023511.2 | c.1241C>T | p.Pro414Leu | missense_variant | 7/8 | XP_016879000.1 | ||
MEAK7 | XM_047434410.1 | c.1241C>T | p.Pro414Leu | missense_variant | 7/8 | XP_047290366.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEAK7 | ENST00000343629.11 | c.1241C>T | p.Pro414Leu | missense_variant | 7/8 | 1 | NM_020947.4 | ENSP00000343635 | P1 | |
MEAK7 | ENST00000566995.5 | c.*655C>T | 3_prime_UTR_variant, NMD_transcript_variant | 8/9 | 5 | ENSP00000454265 | ||||
MEAK7 | ENST00000570036.5 | c.*1296C>T | 3_prime_UTR_variant, NMD_transcript_variant | 8/9 | 2 | ENSP00000455332 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152170Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000357 AC: 89AN: 249098Hom.: 0 AF XY: 0.000290 AC XY: 39AN XY: 134596
GnomAD3 exomes
AF:
AC:
89
AN:
249098
Hom.:
AF XY:
AC XY:
39
AN XY:
134596
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000201 AC: 294AN: 1459398Hom.: 3 Cov.: 30 AF XY: 0.000193 AC XY: 140AN XY: 725964
GnomAD4 exome
AF:
AC:
294
AN:
1459398
Hom.:
Cov.:
30
AF XY:
AC XY:
140
AN XY:
725964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74332
GnomAD4 genome
AF:
AC:
30
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
41
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1241C>T (p.P414L) alteration is located in exon 7 (coding exon 6) of the TLDC1 gene. This alteration results from a C to T substitution at nucleotide position 1241, causing the proline (P) at amino acid position 414 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at